News

ASH 2025: Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukaemia patients eligible for intensive chemotherapy

ASH 2025: Chemo and radiation are comparable as pre-transplant conditioning for B-acute lymphoblastic leukaemia with no measurable residual disease

Triaptosis - an emerging paradigm in cancer therapeutics

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers

Telling women as part of mammography screening that they have dense breasts may have unintended effects

CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer development

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Research reveals how disordered protein regions contribute to cancer-causing condensates

Researchers crack gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases

New tool reveals hidden metabolic weakness in blood cancers

Scientists find cancer weak spot in backup DNA repair system